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ABSTRACT  
Objectives: To explore clinicians’ views and experiences of caring for postnatal women who had 
hypertensive disorders of pregnancy [HDP], awareness of relevant National Institute for Health and 
Care Excellence [NICE] guidance to inform their postnatal management, the extent to which NICE 
guidance was implemented, barriers and facilitators to implementation, and how care could enhanced 
to support women’s future health. 
Design: A qualitative study using semi-structured interviews.  Thematic analysis was utilised for coding 
and theme generation. 
Setting: Four National Health Service [NHS] maternity units and three general practice clinics in South-
East and South-West London. 
Participants: A maximum variation, purposive sample of 20 clinicians with experience of providing 
postnatal care to women following HDP. 
Results: Four main themes were generated. Variation in  knowledge and clinical practice; 
Communication and education; Provision of care; Locus of responsibility for care.  Perceived barriers 
to implementation of NICE guidance included lack of postnatal care plans and pathways, poor 
continuity of care, poor anti-hypertensive medication management, uncertainty around responsibility 
for postnatal care and women’s lack of awareness of the importance of postnatal follow-up for their 
future health. Some clinicians considered women were discharged from in-patient care too soon, as 
primary care clinicians did not have specialist knowledge of HDP management. Most clinicians 
acknowledged the need for better planning, communication and co-ordination of care across health 
settings.   
Conclusions:  Evidence of longer-term consequences for women’s health following HDP is 
accumulating, with potential for NICE guidance to support better outcomes for women if 
implemented. Clinicians responsible for postnatal care following HDP should ensure they are familiar 
with relevant NICE guidance, able to implement recommendations, and involve women in decisions 
about ongoing care and why this is important. The continued low priority and resources allocated to 
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postnatal services will continue to promote missed opportunities to improve outcomes for women, 
their infants and families.  
 
Key Words:  postnatal, maternal morbidity, hypertensive disorders, clinicians, primary care, secondary 
care 
 
Strengths and limitations of this study  
 This study is the first to explore  the views and experiences of UK clinicians who provided 
postnatal care of women who experienced hypertensive disorders in pregnancy, a neglected 
aspect of maternity care. 
 This study reflects increasing evidence that more women are commencing pregnancy at 
increased risk of developing hypertensive disorders in pregnancy due to older maternal age, 
higher BMIs and other medical complications. 
 This study included midwives, obstetricians, GPs, obstetric physicians, and a health visitor, 
reflecting a range of clinical practice across secondary and primary care settings. 
 The study setting included inner-city and urban areas in the south of England. It is possible that 
clinician experiences in other parts of the UK could reflect differences in populations of 
pregnant and postnatal women.  
 
INTRODUCTION 
Hypertensive disorders of pregnancy [HDP] include gestational hypertension, chronic hypertension, 
pre-eclampsia-eclampsia, and pre-eclampsia imposed on chronic hypertension.  HDP are among the 
most severe health problems experienced by women during, and in some cases, following pregnancy, 
and a leading cause of direct maternal deaths globally1.  Although there is no international consensus 
on diagnostic criteria2, HDP affect around 5%-10% of women, with rates increasing due to associations 
with older maternal age, obesity, and diabetes3,4  
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Much of the literature to date has focused on pregnancy management of HDP2,5, but focus is increasing 
on postnatal management2,6,7, reflecting increasing evidence of risk of recurrence of HDP in 
subsequent pregnancies. An individual participant data [IPD] meta-analysis reported a recurrence rate 
of HDP of 20.7% based on 22 cohort studies included in the IPD; recurrence manifested as pre-
eclampsia in 13.8% of the studies, gestational hypertension in 8.6%, and haemolysis [H], elevated liver 
enzymes [EL] and low platelet count [LP; HELLP] syndrome in 0.2%8.   
 
Adverse outcomes are not only restricted to the index pregnancy or subsequent pregnancies, with 
large observational studies and systematic reviews reporting that HDP increase a woman’s lifetime risk 
of cardiovascular disease [CVD] two-to-five-fold compared with women who were normotensive9,10,11.  
An earlier systematic review and meta-analysis also found women who had pre-eclampsia had 
significantly increased odds of a fatal or diagnosed cerebral vascular accident [CVA] and hypertension 
in later life12.    
 
Although underlying mechanisms are currently not well understood, given high and persistent levels 
of maternal morbidity, appropriate and timely clinician input to assess postnatal risk and promote 
health and well-being following HDP is imperative.   Increased awareness of which women may be at 
risk, together with advice offered to women on self-management of potentially modifiable risk factors 
such as weight management and tobacco smoking cessation3,13, highlighted the potential opportunity 
for postnatal care to benefit shorter and longer-term health.     
 
In the UK, the majority of women access maternity care provided by the National Health Service [NHS].   
All women, including those who had HDP, will be discharged following birth to routine contacts with a 
range of clinicians including midwives (for the first 10-14 days postnatally) and health visitors, and 
advised to make an appointment at 6-8 weeks with their general practitioner (GP; family doctor) at 
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which point they are discharged from maternity care. Some women may be offered a follow-up 
consultation with their obstetrician and/or another member of the medical team, but this will depend 
on local clinical arrangements and capacity14. 
 
NICE aims to improve outcomes for patients in the UK who receive NHS care through publication of 
guidance and technology appraisals on provision of effective health, public health, and social care 
across a range of areas, including maternity care. This includes guidance on the routine postnatal care 
all women and their infants should be offered14, and guidance for women who had HDP3,13, which 
includes postnatal lifestyle behaviours, breastfeeding considerations and consideration of longer-
terms risks to a woman’s health.   
 
Despite increasing numbers of women diagnosed with HDP, little is known about clinicians’ 
management of their postnatal care. The aim of this study was to explore the extent to which planning 
and provision of care for women who had HDP reflected the then available NICE guidance on 
hypertensive disorders in pregnancy13 and routine postnatal care14. 
 
METHODS 
Study objectives were to explore: 
 Clinician’s views and experiences of caring for women who had HDP, including awareness of 
relevant NICE guidance and the extent to which planning, and provision of care reflected 
guidance; 
 Barriers and facilitators to implementation of NICE recommendations relevant to postnatal 
management following HDP; 
 Views of where service revisions could be introduced to better meet women’s needs and 
improve quality of care, including the role of multi-disciplinary team [MDT].    
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Setting 
Recruitment took place across four London NHS maternity units and three local general practices based 
in South-East and South-West London. All four units provided specialist maternity care for women with 
more complex pregnancies and/or whose infants required neonatal intensive care, in addition to 
women classed as having a low-risk pregnancy.  Three of the maternity units were tertiary centres, 
with specialist services to treat women and/or infants with the most severe complications of 
pregnancy and birth and were referral centres for units without these services.  The fourth unit was a 
district general hospital. The general practices were all based in the same locale as three of the 
maternity units and offered a range of medical services for the local general population, including 
women living in the hospital catchment area.  All of the study sites provided care to ethnically and 
culturally diverse populations.  
 
Recruitment and participants  
A maximum variation sampling strategy15,16  was used to recruit a range of clinicians responsible for 
providing postnatal care for women who had HDP.  This strategy was employed to provide a 
comprehensive understanding of views and experiences of care offered in-line with the study aim and 
objectives.   Clinicians were identified by local study collaborators as having responsibility for providing 
postnatal care, in-line with study inclusion criteria. Identified clinicians were contacted by a member 
of the research team [AB] who explained the purpose of the study and what participation would 
involve.  Those who agreed to participate, provided written informed consent prior to the research 
interview. 
 
Data collection 
The interview schedule was developed by the authors with input from a stakeholder group of local 
clinicians with expertise in HDP and a Patient and Public Involvement [PPI] group comprising women 
who had previously experienced HDP. Interviews were conducted face-to-face by AB, or if not possible, 
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by telephone, and were intended to be semi-structured, but conversational in nature.  This approach 
allowed for standard questions to be asked in all interviews, but permitted topics of interest to be 
probed further, additional questions to be asked by the interviewer if appropriate, and informed 
exploration of topics in subsequent interviews. Interviews, which lasted for around 30 minutes, were 
transcribed verbatim and transcripts were anonymised and checked for inaccuracies.  
 
Analysis 
Data were managed in NVivo 12 and analysed using thematic analysis17,18, a process characterised by 
inductive, consultative, and open coding of the data19. The six-phase process of thematic analysis17 was 
followed, which entails familiarisation, generating initial codes, searching for and then reviewing 
themes, defining and offering names for those themes.  All data were coded by AB with 20% of the 
transcripts independently coded by Y-SC.  The coding was reviewed by SAS.  The researchers met 
regularly to discuss and revise the themes and ensure analytical rigour, with any discrepancies 
discussed to ensure coding and analysis satisfied all perspectives20. Themes, centred on a core 
organising concept to sustain its explanatory power within the data, were developed from the codes17 
following discussions. All researchers agreed on the final themes.  
 
Sample size sufficiency, data adequacy, and theme saturation were assessed during the analysis 
process using existing models of thematic concordance and data quality21 -23.  This meant data were 
fully saturated with the number of participants recruited, and common themes could be found across 
the dataset, with no new themes being generated by the time the last transcript was analysed. 
 
PATIENT AND PUBLIC INVOLVEMENT 
Women who had experienced HDP informed the original research questions and study design.  Women 
were not involved in the recruitment to, or conduct of this study.  We presented the findings and 
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discussed implications of these through a meeting advertised nationally via the charity: Action on 
Preeclampsia, to women who experienced HDP.  
 
RESULTS 
Thirty-four clinicians were invited to interview, 20 of whom agreed to participate, representing the 
clinical backgrounds of interest (see Table 1).  Five GPs; six obstetricians; seven midwives (including 
case load, consultant, and specialist hypertension midwives); one clinical research fellow (obstetric 
trainee), and one health visitor (a nurse or midwife who has undergone additional training in 
community public health nursing), were recruited and interviewed.  
 
 
 
 
 
 
 
 
 
Table 1. Study ID number and clinical background of participants 
ID Role ID Role 
1 General Practitioner 11 General Practitioner 
2 General Practitioner 12 Consultant Obstetrician 
3 General Practitioner 13 Specialist Midwife for Hypertension 
4 Consultant Obstetrician 14 Consultant Midwife 
5 Obstetric Physician 15 Consultant Obstetrician 
9 
 
6 Community Midwife 16 Research Midwife & Midwifery 
Matron 
7 Specialist Midwife for Hypertension 17 Consultant Obstetrician 
8 Clinical Research Fellow (Obstetric 
Trainee) 
18 Community Midwife 
9 Consultant Midwife 19 General Practitioner 
10 Consultant Obstetrician 20 Health Visitor 
 
 
The analysis generated four main themes: Variation in practice and clinical knowledge; Communication 
and education; Provision of care; Locus of responsibility for care, each with two to four sub-themes, 
which are presented in the following sections. 
 
Variation in practice and clinical knowledge Clinicians’ lack of assessment and knowledge 
Clinicians were aware of the importance of identifying postnatal women with HDP, but some 
acknowledged a general lack of assessment of women’s blood pressure during the postnatal period 
due to the relatively low incidence of adverse outcomes, and lack of recognition of HDP among non-
specialist clinicians.  . 
I think there are other concerns about undertreated hypertension, which we measure poorly. 
We probably under measure it and therefore under report it because we will get away with it 
most of the time, because strokes and eclamptic fits are rare in this population but I think… I 
think walking around with really high blood pressure is probably not good short-term or long-
term.  
(Participant 4 – Consultant Obstetrician) 
 
Concerns were also raised about non-specialists’ awareness of side-effects of anti-hypertensive 
medication they prescribed, as one of the specialist midwives described: 
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The GPs, I’m not sure how much they know… just last week (a woman) had been started on 
medication called methyldopa [anti-hypertensive drug] by the GP, which is not recommended 
postnatally because it makes you very depressed, so that’s why she thinks she wasn’t feeling 
herself at all. We immediately stopped that medication. She said that that GP is not her normal 
GP, it was a locum GP, so maybe they just didn’t know, so it happens sometimes, and they may 
not know. 
(Participant 7 – Specialist Midwife for Hypertension) 
 
The consensus of those interviewed was that more had to be done to educate clinicians, particularly 
those working in primary care settings. Several interviewees suggested postnatal care should be 
provided by specialists in hypertensive care, as primary care clinicians may not have capacity or 
relevant specialist knowledge.   
…we definitely need to re-evaluate the whole postnatal pathway because it's definitely, 
definitely inadequate……… I think what women actually need is direct access to a midwife or 
an obstetrician that they can speak to at any time and get seen at any time… And I mean, 
obviously, that can't just be any midwife or any doctor, I think it needs to be someone with a 
specialist interest in hypertension. 
(Participant 13 – Specialist Midwife for Hypertension) 
 
Clinical decision making based on blood pressure range 
Clinicians offered varied responses when asked what blood pressure parameters they used to manage 
anti-hypertensive medication. Some acknowledged that practice varied between clinicians, with a lack 
of adherence to relevant NICE guidance described. 
…within our hypertension in pregnancy guideline we have got a section on postnatal, with a 
guide on which anti-hypertensives to prescribe, what schedule of reviews should be and fit with 
what the NICE advice is [on BP management]. How effectively that's delivered, I think, is quite 
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variable. So, you can have it on paper, but it doesn't necessarily translate well to what people 
do. 
(Participant 15 – Consultant Obstetrician) 
 
Individual experiences of management of women with HDP shaped the practice of some clinicians. 
Those with more experience of managing HDP expressed greater confidence in their decisions about 
postnatal management: 
NICE say [follow-up checks at] two weeks and six weeks, but as a practicing clinician and on 
the shop floor and having opportunity, I'm far more, I would say, aggressive in making sure 
that we're seeing them more often. I think that those kind of timelines, five days, two weeks 
and six weeks, you've got missed opportunities and actually, women need more or less, and 
less is as important as more. I've seen a lady today that I've had to reduce the antihypertensive 
because nobody is brave enough to do that, even though they've seen two other clinicians.  
(Participant 5 – Obstetric Physician) 
 
The need to regularly review women was viewed as important to ensure anti-hypertensive medication 
management was appropriate. 
…blood pressure’s taken on one day may not be representative of which way they're heading. 
There may be other factors in the immediate post-birth period. Other variables quite strongly 
affect blood pressure and therefore your choice of antihypertensive may be appropriate at this 
moment but may need escalation up or down titration, depending on how factors play out. 
(Participant 4 – Consultant Obstetrician) 
 
Communication and education 
Communication and support between services 
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Clinicians described several barriers to effective communication following in-patient discharge, 
including lack of, or no direct contact with, clinicians involved in a woman’s pregnancy care and lack of 
continuity of postnatal care provider: 
I think communication can be quite tricky at times. I know particularly in our area, 
communication with the midwives isn't quite as easy as it could be in trying to track down who 
is the actual person that's been seeing this lady – quite often, it tends to be different midwives.  
(Participant 20 – Health Visitor) 
 
Clinicians were conscious of ‘gaps’ between care provided by specialists in HDP management in 
hospital and routine primary care services.  They also acknowledged the importance of effective 
communication between clinicians within and across healthcare settings for planning the timing and 
transition of a woman’s care from secondary to primary care.  Some clinicians considered women were 
discharged too soon from specialist services to primary care teams and could benefit from longer 
contact with the secondary care team: 
Ultimately, these women need lifelong care and they need to go back to their GP so it's about 
at what time point we transition them. I think it's too early, at the moment. … I think the 
transition should be in a much more organised and robust way so that women know that they 
have a schedule of reviews delivered by the maternity services and then they have a six-week 
check, which actually works quite well and is bedded in.  
(Participant 15 – Consultant Obstetrician) 
 
Women's engagement with advice and education 
Effective provision of information for women was viewed as key to assist their understanding the 
severity of their disease, and encourage adherence to postnatal management plans, taking prescribed 
medication as advised in terms of dosage and consistent timing, and engaging with primary care for 
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ongoing postnatal monitoring. Although it was noted that women need to engage with the information 
offered, with some women more able to engage than others for a variety of reasons 
Sometimes it's really easy to give advice and sometimes it's really difficult and I wouldn't say 
it's in relation to someone's high blood pressure or diabetes or anything like that, it's just down 
to the woman. Some women are going to listen and some just aren't. 
(Participant 6 – Community Midwife) 
 
Several interviewees referred to the timing of when information was offered could influence how well 
women engaged with understanding the impacts of HDP, recommending that information should be 
provided to women at the earliest opportunity and reiterated at every care contact: 
It may have all been partly intra-partum. Some of them it'll be only, “Oh, your blood pressure 
went up actually in labour, and then we want to get the baby delivered”. So sometimes it's 
quite a short period, and it's a period where lots of other things are going on, and they may not 
have absorbed all those messages.  
(Participant 19 – General Practitioner) 
 
Point of discharge from in-patient care (women with HDP are recommended to birth in an obstetric 
unit, NICE 2014) was viewed as a particularly pertinent time to commence a discussion about a 
woman’s postnatal care choices, including options for contraception: 
I think all women who are hypertensive at delivery should be given a leaflet where all this 
primary information is given to them so that they understand that they look long term for 
contraceptive options. There should be a package that everyone with hypertension in 
pregnancy should receive at the point of discharge with more information links if she wants 
more later on… 
(Participant 12 – Consultant Obstetrician) 
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Others also suggested women needed better antenatal education to enable them to more 
appropriately psychologically prepare for any potential pregnancy complications, such as HDP.   
…I hope that this would prepare them better, that if something happens – if their pregnancy 
takes a slight deviation from their expectations – then they're better prepared to deal with 
that, psychologically. I think that would have an impact on how they behave postnatally… 
(Participant 8 – Clinical Research Fellow) 
 
There was also recognition among clinicians that the postnatal period was a time when women often 
prioritised their newborn infants’ health over their own, certainly in the first few months as they 
adjusted to new family life but also a time when women wanted to feel ‘normal’ again: 
Compliance post-delivery is understandably very poor because they're busy with their babies 
so who's got time to take tablets three times a day?  And they don't feel well on these tablets 
so don't particularly want to take them. 
(Participant 10 – Consultant Obstetrician) 
 
…women don't always take the drugs that are prescribed to them… so it may be that they 
honestly forget, maybe that life is just very busy, but sometimes it's they just don't want to take 
the medication. In pregnancy, that might be because they're worried about the effects on the 
baby. Once they've had the baby, it's because they want to be normal. They're sick of being 'ill'. 
They've had the baby; they want to be like everyone else who's had a baby.  
(Participant 9 – Consultant Midwife) 
 
 
Provision of care  
Improving care  
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Some participants considered postnatal referral pathways should be standardised to reduce risk of 
adverse outcomes if women did not receive prompt care when needed: 
There should be a standardised postnatal pattern where this is where the woman goes… how 
is it okay for a woman to be sitting in a big waiting room with a blood pressure of, you know, 
more than 160/110, it's ridiculous, you know, you're increasing her risk of having a stroke and 
what not, or eclamptic fit. 
(Participant 13 – Specialist Midwife for Hypertension) 
 
Other suggestions for improving care included review of risk factors by an appropriate MDT team, who 
could develop a plan for longer-term follow-up, to be shared with the woman’s GP, alongside 
information for women on longer-term health risks: 
If everything is stable, they [women] should be seen again at six weeks where you can discuss 
future risks. You need to see whether there is a residual disease, whether you need to do more 
investigations and refer to aligned specialities and arrange for long-term follow-up by the GP 
and inform them about the long-term cardiovascular risks and contraception. 
(Participant 12 – Consultant Obstetrician) 
 
Barriers to care reflected need for regular monitoring of women’s blood pressure, medication review 
and ensuring information on drug safety was adequate, especially if women were breastfeeding: 
Before they leave hospital, there are barriers in terms of regular, accurate measurement of 
blood pressure, provision of effective medication, choice of anti-hypertensive with regards to 
breastfeeding, adequacy of information, adequacy of safety data on anti-hypertensives and 
breastfeeding.  
(Participant 4 – Consultant Obstetrician) 
 
Limited capacity effects care provision 
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Clinicians stressed a lack of capacity across the maternity services was an important barrier to 
appropriate and timely care especially in the immediate postnatal period. 
I think the staff feel under-resourced, overstretched, not well supported and with a long list of 
jobs that they're not able to prioritise what's important and what's not so important and then 
meet the expectations of the mothers……… sometimes the midwife, if they find that woman is 
hypertensive, they're not able to get the medical staff to come and address that issue because 
the doctor's based on labour ward or elsewhere. 
(Participant 8 – Clinical Research Fellow) 
 
It was also highlighted that GPs had limited capacity due to their workloads and waiting times for 
women to get an appointment to see them, to engage effectively with postnatal women, meaning that 
follow-up contacts were not tailored to need.  
I think a lot of the work can be done by general practice, but I think, general practice is 
struggling and also, it's engagement with the woman. It's both ways. I think all practices have 
the ability to do this, but the woman has to engage with them as well. If they're being told 
they've got to wait a long time for a GP appointment, they won't engage. 
(Participant 5 – Obstetric Physician) 
 
For some clinicians, despite limited capacity, they went ‘above-and-beyond’ their role especially if a 
woman’s health deteriorated: 
I tell them that they can contact me directly… it's just a responsibility I've taken on myself as I 
don't want them to feel alone postnatally and I don't want them to have to go through A&E. 
Sometimes I'm not here and they do have to go through A&E but if they call… I will see them, 
and they won't have to sit in A&E. I'll just do it ad hoc, grab a consultant and just say, “Look at 
this patient now!” which isn't right, it's not fair. I shouldn't have to do that.  
(Participant 13 – Specialist Midwife for Hypertension) 
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Need for medical care Participants discussed how raised BP, plus adverse blood results could result in 
a longer in-patient stay following the birth, but women were often unaware their BP could remain 
unstable postnatally: 
…anybody whose blood pressure is 140/190, on two occasions, more than four hours apart, or 
150/100 with another factor, such as raised PCR, raised creatinine level, raised ART, low 
platelets……… I say that, postnatally, we do need to monitor you……… sometimes, the women 
are under the impression that once they have given birth, their blood pressure will stabilise. I, 
personally, always say, it's kind of three days before we can see what your blood pressure is 
doing. So, usually, a hospital admission is round about three days, postpartum. 
(Participant 16 – Research Midwife & Midwifery Matron) 
 
Participants in some cases described how they tried to ensure women who required a longer in-patient 
stay had a room of their own in an effort to deter women from discharging themselves from hospital: 
So quite often, if they've got a prolonged stay, you try and find them a side room, so that at 
least they have a bit of privacy but it's really difficult to get them a side room because, 
obviously, there are prioritised women who have had a bereavement or a traumatic labour or 
something. That's often the difficulty I encounter is trying to get them to stay on the postnatal 
ward and discharge them safely. A lot of them want to self-discharge beforehand. 
(Participant 8 – Clinical Research Fellow) 
 
Subsequent pregnancies 
The risks to maternal health in subsequent pregnancies were also referred to by the participants. 
If it's somebody who's already got a pre-existing problem with hypertension and they were 
thinking about subsequent pregnancies, then we'd want to make sure that they were on an 
antihypertensive that was safe in pregnancy in case they were to fall pregnant again.  
(Participant 1 – General Practitioner) 
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Likewise, interviewees discussed the importance of maintenance of a woman’s longer-term health 
after HDP, including counselling women on reducing their risk of HDP in a future pregnancy: 
So, we talk about exercise, diet, maintaining normal BMI and having your blood pressure 
checked, maybe every three, six months, with the GP, just to make sure that they are fit 
following their pregnancy. I will emphasise that they less likely to have a recurrence of their 
pre-eclampsia during future pregnancies if their BMI is normal and they don't have any health 
issues. So, we talk about long term health, off the back of the counselling.  
(Participant 17 – Consultant Obstetrician) 
 
Locus of responsibility for care 
Responsibility placed on the clinician 
Clinicians based in secondary care settings clearly acknowledged their responsibilities when managing 
women with HDP, but felt they could better fulfil these if continuity of care tailored to women’s 
individual BP results were implemented. 
They are seen on the postnatal ward. I would love to have more continuity, but we don't. By 
and large I aim to make a postnatal plan of care… but the individualisation of that, it needs to 
take into account what their blood pressure is postnatally and how rapidly it falls. 
(Participant 4 – Consultant Obstetrician) 
 
This contrasted with those in primary care settings who considered NICE guidance lacked clarity with 
respect to their clinical responsibilities. 
I do think that there is a little bit of a difficulty with knowing what the expectation is of a GP 
when you've got women who are quite complicated. I think that's something that has definitely 
come up in our practice, where you're not really sure what the responsibility is or what the 
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frequency with which you should be checking it is, and I don't think that the NICE guidance is 
so clear on that. 
(Participant 11 – General Practitioner) 
 
The overall feeling from secondary care clinicians was that postnatal women in some circumstances 
(in this case, women who developed gestational hypertension) were perhaps best managed by them, 
however the maternity services did not have capacity or funding for this. 
I absolutely think there needs to be a robust handover and a longer-term transition. But, I think, 
women who developed gestational hypertension are still at risk of post-partum pre-eclampsia 
and often very labile for the first couple of weeks and need quite a lot of adjusting and weaning. 
I think if you're delivering women centred care, this should happen alongside assessing her 
well-being, her baby and I don't think, necessarily, the GP is best placed to do that. I think that 
would be a much more robust system, rather than this, “Oh you've had your baby”; and 
immediately you transition back and go and see your GP. 
(Participant 15 – Consultant Obstetrician) 
 
Furthermore, clinicians discussed that tailoring postnatal care to an individual woman could support 
appropriate clinical decision-making, as getting to know the woman would enable the clinician (in this 
case a midwife) to note changes in her postnatal health and well-being: 
Tailor that care and know the women… from that, you're in a key position as a midwife to make 
real clinical decisions because you know them, you know something's not right……… You can 
talk to them about things and you just see a change in them, you pick up stuff about them that 
might have been lost by a different midwife if every time if they're just doing a urine [test] and 
blood pressure and then off you go. 
(Participant 14 – Consultant Midwife) 
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Responsibility placed on the woman 
Some of the clinicians felt the woman also had to take responsibility for her health following HDP, 
particularly with respect to monitoring of their BP. 
Yes, I suppose they would be seen in in the clinic if the woman came here for an appointment 
to discuss [her hypertension]. Otherwise, I haven't personally been involved with any cases.  
(Participant 3 – General Practitioner) 
 
They've got to think about contraception, and long term if they have got a high BMI, exercising, 
eating sensibly, all these sorts of things. Then they'll have a follow-up with their blood pressure 
more frequently. I usually say to them if they've had it, that they should have their blood 
pressure checked more frequently. 
(Participant 18 – Community Midwife) 
 
There was also the recognition that it was the woman, not the GP, who would arrange postnatal follow-
up. One of the GPs felt women would only be seen if they (the woman) took the initiative and made 
an appointment to see their GP. 
Usually, the women themselves have known and they've been told to come and see their GP 
after two weeks for a blood pressure check……… Postnatal care is very rare, I should think, one 
in the last two years where they've come to have their blood pressure monitor and still on pills. 
(Participant 2 – General Practitioner) 
 
 
Discussion 
This is the first study to explore in-depth the views and experiences of a group of UK clinicians’ of 
postnatal management of women who had HDP, their awareness of relevant NICE guidance, and 
barriers and facilitators to implementation of NICE recommendations.    
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Several important barriers to implementation of NICE guidance were highlighted including lack of 
postnatal care plans and pathways, lack of continuity, poor compliance with anti-hypertensive 
medication management, uncertainty around responsibility for postnatal care and in some cases, 
women’s lack of awareness of the importance of postnatal monitoring and follow-up. Views of current 
routine postnatal provision led some clinicians based in secondary care to consider that women in 
some circumstances should remain under their care for longer, rather than be discharged to non-
specialist ‘routine’ primary care services. Clinicians acknowledged the need for better planning, 
increased awareness of NICE guidance, better co-ordination of care across health settings, better and 
timely information for women and a greater role for MDT planning.   
  
More clinicians will be required to plan and implement guidance to support the management of 
increasing numbers of women likely to experience HDP3,4.  For all clinicians, awareness that HDP can 
persist beyond the birth, knowledge of signs and symptoms of de novo onset, and the sharing of 
relevant information with women and their families14,24 could make a significant difference to 
outcome.   
 
Findings indicate the postnatal period remains a neglected aspect of a woman’s maternity care, despite 
increasing evidence of widespread and chronic physical and psychological maternal morbidity25.  
Women in the UK are still more likely to die following birth than during pregnancy26, however maternal 
deaths as a result of HDP declined considerably between 2009-2011 (11 women died, 0.42 per 100,000 
maternities, 95% CI 0.21-0.76) and 2012-2014 (three women died, 0.11 per 100,000 maternities, 95% 
CI 0.02-0.34)27, this reduction attributed to implementation of research, audit and evidence-based 
guidance. 
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Whilst the Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries [MBRRACE-
UK] findings are very reassuring, none of the opportunities highlighted to further improve care referred 
to the postnatal period and beyond, despite 11 of the 14 maternal deaths between 2009-2014 
occurring between 1 and 42 days of giving birth27.  With evidence of risks of HDP on a woman’s future 
cardio-vascular health4, risk of re-occurrence of HDPs in a future pregnancy11, and evidence that 
around a third of eclampsia cases and more than half of strokes associated with severe pre-eclampsia 
occur postnatally6.28, postnatal care cannot be ignored.   
 
The variation in content of care and lack of awareness of antihypertensive medication as 
recommended by NICE3,13 found in the current study supports a small on-line survey of UK clinicians of 
antihypertensive adjustment postnatally, which aimed to explore prescribing clinicians’ approaches to 
down-titration of antihypertensive medication following birth2.  Of the 101/390 (26%) secondary and 
primary care clinicians approached who completed the survey, labetalol was the commonest 
antihypertensive drug prescribed.  Most clinicians reported adhering to national guidelines when 
reducing but not increasing women’s medication, with wide variation in practice. 
 
The same research team subsequently published results of a feasibility trial of women’s self-
management of blood pressure29.  Ninety-one (49%) of 186 women approached from five NHS units 
who had gestational hypertension or pre-eclampsia which required postnatal anti-hypertensive 
management were recruited and randomised to self-management (n=45) or usual care (n=46).  The 
self-management intervention, which commenced following in-patient discharge, comprised daily 
home BP monitoring and automated medication reduction via telemonitoring.  Feasibility outcomes 
included recruitment, retention and compliance with follow-up; 90% of women completed follow-up.  
Intervention women had lower BP, with the largest difference at six weeks postnatally.  Diastolic BP 
was significantly lower in the intervention group to six months postnatally.  Study limitations included 
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that women were mostly white and from middle-class backgrounds, nevertheless a larger RCT with BP 
as the primary outcome is an important next step29. 
 
Robust evidence to support postnatal anti-hypertensive management is needed.  This includes studies 
which directly compare outcomes of different hypertensive drugs and BP thresholds for medication 
adjustment29, and studies which address why there are disparities in outcomes among women of 
different ethnic groups, such as the recent finding that women of black ethnicity with chronic 
hypertension had a significantly greater risk of adverse perinatal outcomes compared to white 
women30.   
 
What is clear based on our findings is that greater awareness of, and compliance with, NICE 
guidance3,13,14 could enhance some postnatal outcomes. These include developing postnatal care plans 
and pathways during pregnancy13 to inform appropriate timing of transfer from secondary to primary 
care services and the clinicians who should be involved.   Greater involvement of the MDT could be of 
benefit, with consideration of a postnatal MDT consultation to assess women’s health needs going 
forward, and the development of a care plan which could be shared with the woman’s GP25.  Continuity 
of midwifery care could be supported postnatally for as long as the woman and midwife felt was 
necessary, with a co-ordinating clinician identified (for example, the midwife or GP) to sign-post 
women for additional medical support as and when required. Information on breastfeeding when 
taking anti-hypertensive drugs should be offered to all women3,13, preferably when medication is first 
prescribed, to enable women to make informed decisions about infant feeding.  Our findings clearly 
highlight all clinicians should familiarise themselves with current guidance on recommended anti-
hypertensive medication for women who are or are not breastfeeding, even if not the prescribing 
clinician, to ensure they can advise women appropriately3,13.  
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Some clinicians in our study were advising women on approaches to self-manage their health to reduce 
future risk of the consequences of HDP on their health, including lifestyle advice.  Of concern is that a 
lack of an appropriate care pathway postnatally could delay treatment, including pre-conception care 
planning, to potentially benefit outcomes of subsequent pregnancies. NICE recommends weight 
management support and other lifestyle behaviours are discussed with women, with advice reflecting 
women’s individual circumstances, and reiterated as needed at each primary care consultation3,13,14. 
Women at risk of future CVD based on their pregnancy history will potentially require more frequent 
screening beyond the postnatal period, although robust evidence is needed of the benefit of this10.   
What NICE guidance does not currently specifically support is flexibility with respect to the duration of 
postnatal care an individual woman may require. Current guidance3,13,14 ‘assumes’ all women are 
‘recovered’ from their pregnancy and birth within the 6 to 8-week postnatal period, when this may not 
be the case.  We do not yet have evidence of what model of postnatal care would be of most benefit 
for women who have medically complex pregnancies, an area which needs urgent attention25.   
 
As a qualitative study, generalisability may be limited. The study was undertaken in London and it is 
likely that clinicians’ experiences will differ in terms of the population of women they are likely to care 
for, the environment of care and range of specialist maternity services they can access.  However, 
there were several strengths.  We interviewed a wide range of secondary and primary care-based NHS 
clinicians based in inner-city and urban areas, providing care to women and families from a wide range 
of ethnicities, socio-demographic and socio-economic backgrounds.  Some clinicians were linked to 
tertiary NHS maternity units which care for women with the most serious medical complications and 
as such, were more likely to be ‘experts’ in HDP management and to have greater insight into some of 
the issues raised.   
  
Conclusion 
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Evidence of longer-term maternal health consequences following HDP is accumulating. Clinicians 
should ensure relevant NICE guidance is implemented, that they are familiar with guidance, and that 
women are involved in decisions about ongoing care and why this is important.  The continued low 
priority accorded to postnatal care means that missed opportunities to improve outcomes for women, 
their infants and families will continue. 
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